CVS Health upgraded at TD Cowen after insurer unveils 2025 Medicare Advantage plan

Investing.com -- Analysts at TD Cowen have raised their rating of CVS Health (NYSE:CVS) to "Buy" from "Hold", citing changes to its 2025 Medicare Advantage plan benefits announced earlier this week. ca.finance.yahoo.com/news/cvs-health-upgraded-td-cowen-110924963.html